Evidence map›Paper›PMID 28181140›Full record

ArticleCytotechnology2017

Real architecture For 3D Tissue (RAFT™) culture system improves viability and maintains insulin and glucagon production of mouse pancreatic islet cells.

Gabor J Szebeni, Zsuzsanna Tancos, Liliana Z Feher, Robert Alfoldi, Julianna Kobolak, Andras Dinnyes, Laszlo G Puskas

Open access · hybridAbstract read
In one paragraph

Article in Cytotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Imidazo[1,2-International journal of molecular sciences · 2020
    Article
  6. Article
  7. Article
  8. Imidazo[1,2-Molecules (Basel, Switzerland) · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gabor J SzebeniAvidin Ltd, Also kikötő sor 11/D, Szeged, H6726, Hungary.
Zsuzsanna TancosBiotalentum Ltd, Szent-Györgyi Albert 4, Gödöllő, H2100, Hungary.
Liliana Z FeherAvidin Ltd, Also kikötő sor 11/D, Szeged, H6726, Hungary.
Robert AlfoldiAvidin Ltd, Also kikötő sor 11/D, Szeged, H6726, Hungary.
Julianna KobolakBiotalentum Ltd, Szent-Györgyi Albert 4, Gödöllő, H2100, Hungary.
Andras DinnyesBiotalentum Ltd, Szent-Györgyi Albert 4, Gödöllő, H2100, Hungary. andras.dinnyes@biotalentum.hu.
Laszlo G PuskasAvidin Ltd, Also kikötő sor 11/D, Szeged, H6726, Hungary. laszlo@avidinbiotech.com.
BioTalentum (Hungary) · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an unmet medical need for the improvement of pancreatic islet maintenance in culture. Due to restricted donor availability it is essential to ameliorate islet viability and graft engraftment. The aim of this study was to compare the standard tissue culture techniques with the advanced Real Architecture For 3D Tissue (RAFT™) culture system in terms of viability and hormone production. Here, we first report that islets embedded in RAFT™ collagen type I advanced tissue culture system maintain their tissue integrity better than in monolayer and suspension cultures. The Calcein violet assay and Annexin V/propidium-iodide staining show higher cell viability in the RAFT™ culture system. Quantitative real-time PCR data showed that RAFT™ increases insulin expression after 18 days in culture compared to traditional methods. Enhanced insulin and glucagon production was further verified by immunofluorescent staining in a time-course manner. These results indicate that RAFT™ tissue culture platform can be a promising tool to maintain pancreatic islet spheroid integrity and culture islets for downstream high throughput pharmacological studies ex vivo.

Indexed as

3D cultureInsulinPancreas isletRAFT™

Identifiers

PMID28181140
PMCPMC5366973
OpenAlexW2586211269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.